Compared to wild-type (2fTGH, fibrosarcoma) cells, DRAK1 induction was significantly reduced in STAT1-defective cells (U3A, derived from 2fTGH and defective in type I IFN signaling), while DRAK2 levels remained unchanged (Figure 1E,F). The gene discussed is STK17A; the disease is fibrosarcoma.